INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ALPHAGAN® Purite® Ophthalmic solution

SCHEDULING STATUS
Schedule 3

PROPRIETARY NAME
(and dosage form):

ALPHAGAN® Purite® Ophthalmic solution

COMPOSITION
Each mL contains:
Brimonidine tartrate 1,5 mg

PHARMACOLOGICAL CLASSIFICATION
A.15.4 Ophthalmic preparations. Other.

Removed from this site: June 2018
Advised by: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2017